can a doctor prescribe semaglutide Your for Weight Loss? Semaglutide Prescription for Weight Loss

45.3% of participants on the highest dose lost 30% or more of their body weight TRIUMPH-4 knee osteoarthritis + obesity (Dec 2025) 28.7% weight loss at 68 weeks TRANSCEND-T2D-1 type 2 diabetes (Mar 19, 2026) A1C -2.0%, 16.8% weight loss at 40 weeks ADA 86th Scientific Sessions (Jun 6-10, 2026, New Orleans) the full TRIUMPH-1 + TRANSCEND-T2D-1 panel, the most detailed public presentation of the Phase 3 data see our ADA 2026 retatrutide coverage Still expected in 2026: TRIUMPH-2 (obesity in type 2 diabetes, with a nested OSA protocol): extends the obesity case into the T2D population and supports a sleep-apnea indication

New indications and more players in the field The number of indications for GLP-1s continues to grow steadily, like Ozempics recent approval for adults with type 2 diabetes and chronic kidney disease, as well as benefits beyond weight and blood sugar management (e.g., peripheral artery disease, liver disease, heart disease , sleep apnea, osteoarthritis)

After completion as monitored by UPLCMS, the reaction was concentrated in vacuo

Earlier in February 2026, Novo Nordisk sued Hims & Hers Health over its compounded semaglutide products, following the rapid launch and withdrawal of a cutprice "Compounded GLP1 Pill" and mounting FDA scrutiny of the company's weightloss offerings and affiliated pharmacy practices

These medications now account for more than 15 percent of annual claims for more than a quarter of employers

With a family-oriented approach and highly skilled providers, we are committed to supporting you every step of the way on your wellness journey